Literature DB >> 32091954

Palliative Care and Hospice Referrals in Patients with Decompensated Cirrhosis: What Factors Are Important?

John H Holden1, Hani Shamseddeen1, Amy W Johnson2, Benjamin Byriel3, Kavitha Subramoney2, Yao-Wen Cheng4, Akira Saito1, Marwan Ghabril1, Naga Chalasani1, Greg A Sachs2,5, Eric S Orman1.   

Abstract

Background: Palliative care (PC) and hospice care are underutilized for patients with end-stage liver disease, but factors associated with these patterns of utilization are not well understood. Objective: We examined patient-level factors associated with both PC and hospice referrals in patients with decompensated cirrhosis (DC). Design: Retrospective cohort study. Setting/Subjects: Patients with DC hospitalized at a single tertiary center and followed for one year. Measurements: We assessed PC and hospice referrals during follow-up and examined patient-level factors associated with the receipt of PC and/or hospice, as well as associated clinical outcomes. We also examined late referrals (within one week of death).
Results: Of 397 patients, 61 (15.4%) were referred to PC, 71 (17.9%) were referred to hospice, and 99 (24.9%) were referred to PC and/or hospice. Two hundred patients (50.4%) died during the one-year follow-up. In multivariable logistic regression, referral to PC was associated with increased comorbidity burden, ascites, increased MELD (Model for End-Stage Liver Disease)-Na score, lack of listing for liver transplant, and unmarried status. Hospice referral was associated with increased comorbidities, portal vein thrombosis, and hepatocellular carcinoma. PC referrals were late in 68.5% of cases, and hospice referrals were late in 62.7%. Late PC referrals were associated with younger age and married status. Late hospice referrals were associated with younger age and recent alcohol use. Conclusions: PC and hospice is underutilized in patients with DC, and most referrals are late. Patient-level factors associated with these referrals differ between PC and hospice.

Entities:  

Keywords:  hospice; liver cirrhosis; palliative care

Mesh:

Year:  2020        PMID: 32091954      PMCID: PMC7404816          DOI: 10.1089/jpm.2019.0501

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  33 in total

Review 1.  Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.

Authors:  Gennaro D'Amico; Guadalupe Garcia-Tsao; Luigi Pagliaro
Journal:  J Hepatol       Date:  2005-11-09       Impact factor: 25.083

2.  A staggered edge: End-of-life care in patients with severe mental illness.

Authors:  Daniel Shalev; Katherine Brewster; Melissa R Arbuckle; Jon A Levenson
Journal:  Gen Hosp Psychiatry       Date:  2016-10-20       Impact factor: 3.238

3.  Palliative care in cirrhosis with decompensation.

Authors:  Angela Plunkett; Marianne Mortimore; Phillip Good
Journal:  Intern Med J       Date:  2019-07       Impact factor: 2.048

4.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

5.  Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population.

Authors:  Winnie Y Zou; Hashem B El-Serag; Yvonne H Sada; Sarah L Temple; Shubhada Sansgiry; Fasiha Kanwal; Jessica A Davila
Journal:  Dig Dis Sci       Date:  2018-03-05       Impact factor: 3.199

6.  Most Individuals With Advanced Cirrhosis Have Sleep Disturbances, Which Are Associated With Poor Quality of Life.

Authors:  Marwan Ghabril; Mollie Jackson; Raghavender Gotur; Regina Weber; Eric Orman; Raj Vuppalanchi; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2017-02-03       Impact factor: 11.382

7.  Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?

Authors:  Fasiha Kanwal; Ron D Hays; Amy M Kilbourne; Gareth S Dulai; Ian M Gralnek
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

8.  Significant Morbidity and Mortality Among Hospitalized End-Stage Liver Disease Patients in Medicare.

Authors:  Cristal L Brown; Bradley G Hammill; Laura G Qualls; Lesley H Curtis; Andrew J Muir
Journal:  J Pain Symptom Manage       Date:  2016-06-03       Impact factor: 3.612

9.  Late referral to palliative care consultation service: length of stay and in-hospital mortality outcomes.

Authors:  Jessi Humphreys; Stephanie Harman
Journal:  J Community Support Oncol       Date:  2014-04

10.  Supportive and palliative care in people with cirrhosis: International systematic review of the perspective of patients, family members and health professionals.

Authors:  Joseph T S Low; Gudrun Rohde; Katherine Pittordou; Bridget Candy; Sarah Davis; Aileen Marshall; Paddy Stone
Journal:  J Hepatol       Date:  2018-09-20       Impact factor: 25.083

View more
  7 in total

1.  Palliative long-term abdominal drains for the management of refractory ascites due to cirrhosis: a consensus document.

Authors:  Lucia Macken; Margaret Corrigan; Wendy Prentice; Fiona Finlay; Joanne McDonagh; Neil Rajoriya; Claire Salmon; Mhairi Donnelly; Catherine Evans; Bhaskar Ganai; Joan Bedlington; Shani Steer; Mark Wright; Ben Hudson; Sumita Verma
Journal:  Frontline Gastroenterol       Date:  2022-06-10

Review 2.  Current Medical Treatment for Alcohol-Associated Liver Disease.

Authors:  Gustavo Ayares; Francisco Idalsoaga; Luis A Díaz; Jorge Arnold; Juan P Arab
Journal:  J Clin Exp Hepatol       Date:  2022-02-12

3.  Palliative Care, Patient-Reported Measures, and Outcomes in Hospitalized Patients With Cirrhosis.

Authors:  Eric S Orman; Andrew Yousef; Chenjia Xu; Hani Shamseddeen; Amy W Johnson; Lauren Nephew; Marwan Ghabril; Archita P Desai; Kavish R Patidar; Naga Chalasani
Journal:  J Pain Symptom Manage       Date:  2022-02-21       Impact factor: 5.576

Review 4.  Hospice care for end stage liver disease in the United States.

Authors:  Eric S Orman; Amy W Johnson; Marwan Ghabril; Greg A Sachs
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2021-02-24       Impact factor: 4.095

5.  Palliative Care Always: Hepatology-Virtual Primary Palliative Care Training for Hepatologists.

Authors:  Jan C DeNofrio; Manisha Verma; Andrzej S Kosinski; Victor Navarro; Tamar H Taddei; Michael L Volk; Marie Bakitas; Kavitha Ramchandran
Journal:  Hepatol Commun       Date:  2021-10-31

6.  Impact of Palliative Care Services on Treatment and Resource Utilization for Hepatorenal Syndrome in the United States.

Authors:  Charat Thongprayoon; Wisit Kaewput; Tananchai Petnak; Oisin A O'Corragain; Boonphiphop Boonpheng; Tarun Bathini; Saraschandra Vallabhajosyula; Pattharawin Pattharanitima; Ploypin Lertjitbanjong; Fawad Qureshi; Wisit Cheungpasitporn
Journal:  Medicines (Basel)       Date:  2021-05-12

7.  Analysis of end-of-life treatment and physician perceptions at a university hospital in Germany.

Authors:  Nicole Heerde; Wolf-Karsten Hofmann; Ralf-Dieter Hofheinz; Sylvia Büttner; Deniz Gencer
Journal:  J Cancer Res Clin Oncol       Date:  2021-05-05       Impact factor: 4.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.